Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Ping An Biomedical Co Ltd's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Ping An Biomedical Co Ltd (PASW) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q4 2025
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
Share of combined sales, Q4 2025
Revenue Growth Y/Y
-
Q4 2025
Net Margin
-37.57 %
Q4 2025

Key Findings: Ping An Biomedical Co Ltd vs Its Competitors

  • TTM: Trailing 12-month revenue of 5M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+300.0% annualized vs trailing 12 months).
  • Scale: Ping An Biomedical Co Ltd ranks #43 of 49 companies by market capitalization in the Apparel, Footwear & Accessories industry, holding 0.0% of industry market cap.
  • Peer revenue share: Ping An Biomedical Co Ltd accounted for 100.0% of combined revenue among its tracked peer group.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

PASW Sales vs. its Competitors, Q4 2025

Ping An Biomedical Co Ltd generated 100.00 % of the combined sales of its peer group.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/PASW/competitors
https://api.csimarket.com/api/v1/companies/PASW/relationships
https://api.csimarket.com/api/v1/companies/PASW/similar
Programmatic access for models, analytics, and integration workflows.

Ping An Biomedical Co Ltd's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Ping An Biomedical Co Ltd - - - -
Similar-Size Competitors (6) 33% 33% 0% 50%

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q4 2025

100%market share
  • Ping An Biomedical Co Ltd100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Ping An Biomedical Co Ltd and its 0 tracked competitors.

See Ping An Biomedical Co Ltd's full market share breakdown »

PASW Stock Performance relative to its Competitors

PASW Competitors (weighted) Percent change over the selected range

Ping An Biomedical Co Ltd's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
100%beat U.S.A. 500
High-Confidence
(1 of 1)
0%beat U.S.A. 500
Similar-Size
(0 of 6)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Ping An Biomedical Co Ltd -89.30 % Underperformed
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (1) 40.4% 63.2%
Similar-Size Competitors (6) 40.4% 63.2%
Similar Growth & Profitability (0) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Ping An Biomedical Co Ltd's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

PASW Stock Performance relative to High-Confidence Competitors

PASW High-Confidence Competitors (equal-weighted, 1) Percent change over the selected range

PASW Stock Performance relative to Similar-Size Competitors

PASW Similar-Size Competitors (equal-weighted, 7) Percent change over the selected range

Ping An Biomedical Co Ltd's Comment on Competition and Industry Peers

The company operates in the competitive and fragmented apparel supply chain management (SCM) market in China. Service providers in this market compete on product design, price, quality control, and delivery. Competitors may offer products comparable or superior to those of the company and may adapt more quickly to industry trends and market changes. The company focuses on vertically integrated operations, specialization in the apparel industry, personalized customer experience, and providing high-quality products at competitive prices. Retail brands in the apparel SCM market increasingly demand higher quality, shorter lead times, and competitive pricing.

Ping An Biomedical Co Ltd's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
Oneconnect Financial Technology Co Ltd Named by the company 85% 2022 to 2026 3
Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Ping An Biomedical Co Ltd's named competitors require a Commercial License.

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.

Ping An Biomedical Co Ltd's Business Segment Mix vs Peers

Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).
Company Largest Segment 2nd Segment 3rd Segment
Ping An Biomedical Co Ltd Sales of Finished Garments 35.99 % - -

Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).

Get the full CSIMarket dataset: Subscribe API License